BRCA1 and BRCA2

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Preliminary matched data presented at SABCS point to a personalized option for women facing surgical menopause after risk-reducing ovary removal.